Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of s… https://t.co/kYyOAY6MOf
    about 10 hours ago
  • New post on Science and Enterprise: NIH Funds Programmable mRNA to Treat Cancer https://t.co/DKptaY956d #Science #Business
    about 10 hours ago
  • Attn @ArcticFisheries .. Why Migraine Sufferers May Want to Eat More Fish https://t.co/3AaUvjuNqT
    about 13 hours ago
  • Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and ther… https://t.co/iJUJA00PmY
    about 1 day ago
  • New post on Science and Enterprise: Sanofi Acquires mRNA Developer in $3.2B Deal https://t.co/lRVt9pv3bq #Science #Business
    about 1 day ago

Please share Science & Enterprise

Infographic – What is Crispr?

Crispr explainer

(CB Insights)

9 Feb. 2019. One hot topic we’ve covered almost from the beginning at Science & Enterprise is Crispr — clustered, regularly interspaced short palindromic repeats — a genome editing technique derived from bacterial defense systems. Our first story about the technique dates back to August 2013, but we were also among the early chroniclers of financing for start-up companies commercializing Crispr like Editas Medicine and Crispr Therapeutics, now in full swing developing treatments and licensing their technologies.

Even as Crispr has gained commercial traction and public attention, there’s still a need for a good illustrated introduction to the technique, which or friends at CB Insights published on Thursday, our infographic for this weekend. The chart is part of a larger report on the state of Crispr technology and its applications. Listed below are links to some of our recent stories on Crispr.

More from Science & Enterprise:

*     *     *

1 comment to Infographic – What is Crispr?